Evidence map›Paper›PMID 41290681›Full record

ArticleNature communications2025

Plastic hepatocyte states limit liver cancer development.

Lauren S Strathearn, Yuki Hayata, Abhinav Illendula, Charles K Hewett, Mingjia Chen, Guoshun He, María Escribano-Cebrián, Brianna Jarboe, Laura Gómez-Tomé, Nicola de Prisco and 6 more

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Lauren S Strathearn *Cancer Signaling and Microenvironment Program, Fox Chase Cancer Center, Philadelphia, PA, USA.
Yuki Hayata *Cancer Signaling and Microenvironment Program, Fox Chase Cancer Center, Philadelphia, PA, USA.
Abhinav IllendulaCancer Signaling and Microenvironment Program, Fox Chase Cancer Center, Philadelphia, PA, USA.ORCID 0009-0004-8245-7211
Charles K HewettCancer Signaling and Microenvironment Program, Fox Chase Cancer Center, Philadelphia, PA, USA.
Mingjia ChenCancer Signaling and Microenvironment Program, Fox Chase Cancer Center, Philadelphia, PA, USA.
Guoshun HeCancer Signaling and Microenvironment Program, Fox Chase Cancer Center, Philadelphia, PA, USA.
María Escribano-CebriánCancer Signaling and Microenvironment Program, Fox Chase Cancer Center, Philadelphia, PA, USA.ORCID 0009-0006-7520-4499
Brianna JarboeCancer Signaling and Microenvironment Program, Fox Chase Cancer Center, Philadelphia, PA, USA.ORCID 0009-0008-5374-5125
Laura Gómez-ToméCancer Signaling and Microenvironment Program, Fox Chase Cancer Center, Philadelphia, PA, USA.
Nicola de PriscoCancer Signaling and Microenvironment Program, Fox Chase Cancer Center, Philadelphia, PA, USA.
Michael SlifkerBiostatistics and Bioinformatics Facility, Fox Chase Cancer Center, Philadelphia, PA, USA.
Satoshi KawamuraDepartment of Gastroenterology and Hepatology, Graduate School of Medicine, Mie University, Tsu, Japan.
Hayato NakagawaDepartment of Gastroenterology and Hepatology, Graduate School of Medicine, Mie University, Tsu, Japan.ORCID 0000-0002-6973-5094
David RossellDepartment of Economics, Universitat Pompeu Fabra, Barcelona, Spain.
Ben Z StangerAbramson Family Cancer Research Institute, Division of Gastroenterology, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.ORCID 0000-0003-0410-4037
Joan Font-BurgadaCancer Signaling and Microenvironment Program, Fox Chase Cancer Center, Philadelphia, PA, USA. joan.font-burgada@fccc.edu.ORCID 0000-0003-3372-418X

Funding

WORD PROCESSING CENTER--COREP30CA006927 · NCI · RESEARCH INST OF FOX CHASE CAN CTR · PI Dietmar J Kappes · 1985 to 2026
$138.8M
New tools for understanding metastasis through tissue resident cells: enabling an Extensive Medicine strategy for metastatic diseaseDP2CA258224 · NCI · RESEARCH INST OF FOX CHASE CAN CTR · PI FONT-BURGADA, JOAN · 2020 to 2020
$2.8M
Hepatic Tissue Integrity and Clonal Fitness: Key Factors in Controlling β-Catenin Induced OncogenesisR01CA289703 · NCI · RESEARCH INST OF FOX CHASE CAN CTR · PI Joan Font-Burgada · 2024 to 2026
$1.7M
Molecular Biology and Genetics: Signaling, Epigenetics and Genome MaintenanceT32GM142606 · NIGMS · TEMPLE UNIV OF THE COMMONWEALTH · PI Xavier Grana, Kelly A Whelan · 2021 to 2026
$1.5M
NCI NIH HHS DP2 CA258224NCI NIH HHS P30 CA006927NCI NIH HHS R01 CA289703NIGMS NIH HHS T32 GM142606U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI) P30CA006927U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI) R01CA289703U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (NIGMS) T32GM142606U.S. Department of Health & Human Services | NIH | NIH Office of the Director (OD) DP2CA258224
6 · The paper itself

Abstract

The liver has remarkable regenerative capacity owing to the boundless proliferative potential of hepatocytes. During liver injury, sustained regeneration must be balanced by mechanisms limiting overgrowth and tumorigenesis. Epithelial plasticity is frequently observed during liver damage and is thought to mediate production of biliary epithelial cells (BECs) or hepatocytes, depending on tissue needs. Here we show that hepatocytes persisting in plastic states are present in virtually all liver injury contexts, representing the predominant outcome of hepatocyte reprogramming rather than their full BEC conversion. By developing tools to trap mouse hepatocytes in plastic states in vivo and using models of regeneration and transplantation, we show that plastic hepatocytes are refractory to proliferation cues from the microenvironment. Unlike terminally differentiated hepatocytes, plastic hepatocytes resist proliferation driven by endogenous oncogenic stimuli. Thus, acquisition of plastic states represents a protective mechanism that constrains hepatocyte proliferation, limiting overgrowth and tumorigenesis during liver disease.

Indexed as

Cell PlasticityHepatocytesLiver NeoplasmsAnimalsCarcinogenesisCell DifferentiationCell ProliferationEpithelial CellsHumansLiverLiver RegenerationMaleMiceMice, Inbred C57BL

Identifiers

PMID41290681
PMCPMC12748961

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.